Moolec Science S.A.
MLEC · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 69.7% | 2.2% | -27.8% | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -25.5% | 0.9% | -4.7% | 4.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -43.6% | -68.6% | -155.3% | -29.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -91.8% | -123% | -166.5% | -66.5% |
| EPS Diluted | -0.06 | -0.05 | -0.07 | -0.04 |
| % Growth | -20% | 28.6% | -75% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |